BioMerieux SA (BIM)
bioM�rieux SA engages in the provision of diagnostic solutions which determine the source of disease and contamination. The company provides clinical solutions such as antimicrobial resistance, C. difficile infection, human immunodeficiency virus, and emergency department patient management. It also specializes in the field of in vitro diagnostics. The company was founded in 1963 and is headquartered in Marcy l'Etoile, France.
|Market Price at 17-01-2018||77,70 €|
|Price to Earnings Ratio||93,77|
|Market Capitalisation||9.232,18 € (million)|
|Return on Equity (ROE)||11,06%|